You are here: Industry Insights > Biologics

News List

Cytovance Biologics Offers Licensing for Plasmid DNA Manufacturing contractpharma
March 10, 2021
The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale.
Wacker Strengthens Biologics Business contractpharma
February 05, 2021
The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.
Almac Expands Global Biologics Testing Services contractpharma
January 28, 2021
Almac Sciences, a member of the Almac Group, has expanded its biologics testing laboratory with significant investment in mass spectrometry equipment.
Charles River Partners with JADE contractpharma
January 15, 2021
Charles River Laboratories International Inc. has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management services for the biopharmaceutical industry.
Cytiva delivers modular biologics factory to Lonza prnasia
January 14, 2021
Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.
Abzena Unveils New Biologics GMP Manufacturing Site contractpharma
January 12, 2021
Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has added a sixth global site that will augment cGMP manufacturing capacity for mammalian biologics.
CDMO Stelis Continues Expansion contractpharma
December 02, 2020
Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...
Cue Biopharma, Merck Extend Biologics Research Alliance contractpharma
November 20, 2020
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.
Microbial contract biomanufacturing market to be worth $9.3 billion by 2030 europeanpharmaceuticalreview
November 18, 2020
A new analysis suggests that Europe and North America will capture more than 80 percent of the $9.3 billion market by 2030.
PathoQuest, Charles River Expand Strategic Pact contractpharma
November 13, 2020
Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.

Previous page 1 2 3 4 5 6 7 8 Next page